Cor Vasa 2009, 51(1):45-48 | DOI: 10.33678/cor.2009.012
Monitoring the dynamics of B-natriuretic peptide may have a major impact on the choice of treatment of the patient with heart failure
- 1 Klinika kardiologie
- 2 Základna radiodiagnostiky a intervenční radiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
The paper seeks to provide evidence that repeat measurement of serum B-natriuretic peptide levels may contribute to deciding on the therapeutic option to be chosen for the heart failure patient. We report the case of advanced heart failure in a patient with spongiform cardiomyopathy placed urgently on a waiting list for heart transplantation. The ensuing course was unexpectedly favorable and the patient is still being treated conservatively. A decrease in B-natriuretic peptide levels served as an early marker of resolving signs of advanced heart failure.
Keywords: Heart failure; Spongiform cardiomyopathy; B-natriuretic peptide
Published: January 1, 2009 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
Málek I, Hegarová M, Lupínek P, Tintěra J. Monitoring the dynamics of B-natriuretic peptide may have a major impact on the choice of treatment of the patient with heart failure. Cor Vasa. 2009;51(1):45-48. doi: 10.33678/cor.2009.012.
References
- Špinar J, Hradec J, Meluzín J, a spol. Doporučení pro diagnostiku a léčbu chronického srdečního selhání ČKS 2006. Cor Vasa 2007;49:K5-K34.
- Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). The task force for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.
Go to original source... 
Go to PubMed... - Oechslin EN, Attenhofer JCH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500. Go to original source... Go to PubMed...
- Troughton RW, Frampton ChM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (BNP) concentrations. Lancet 2000;355:1126-30. Go to original source... Go to PubMed...
- Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. JACC 2007;49:1733-9. Go to original source... Go to PubMed...
- Shah MR, Califf RM, Nohria A, et al. STARBRITE: a randomized pilot trial of BNP-guided therapy in patients with advanced heart failure. Paper presented at: American Heart Association Scientific Sessions; November 12-15, 2006, Chicago, IL.
- Lainchbury JG, Troughton RW, Frampton CM, et al. NT-proBNP guided drug treatment for chronic heart failure: design and methods in the BATTLE-SCARRED trial. Eur J Heart Fail 2006;8:532-8. Go to original source... Go to PubMed...
- Brunner-La-Rocca HP, Buser PT, Schindler R, et al. Management of elderly patients with congestive heart failure - Design of the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Am Heart J 2006;151:949-55. Go to original source... Go to PubMed...